Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A Randomized, Balanced, Phase 1, Multiple-dose, Open-label, Two-treatment, Two-period, Two-sequence, Crossover, Relative Bioavailability Study to Investigate Lithium Brain/Plasma Pharmacokinetics and Safety of an AL001 Oral Capsule Compared to a Marketed Immediate-release Lithium Carbonate Capsule in Healthy Adult Subjects

Next Previous
Trial Profile

A Randomized, Balanced, Phase 1, Multiple-dose, Open-label, Two-treatment, Two-period, Two-sequence, Crossover, Relative Bioavailability Study to Investigate Lithium Brain/Plasma Pharmacokinetics and Safety of an AL001 Oral Capsule Compared to a Marketed Immediate-release Lithium Carbonate Capsule in Healthy Adult Subjects

Status: Active, no longer recruiting
Phase of Trial: Phase I

Latest Information Update: 01 Oct 2025

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Lithium cocrystal Alzamend Neuro (Primary) ; Lithium
  • Indications Alzheimer's disease; Bipolar disorders; Major depressive disorder; Post-traumatic stress disorders
  • Focus Adverse reactions; Pharmacokinetics
  • Acronyms Lithium in Brain
  • Sponsors Alzamend Neuro

Most Recent Events

  • 28 Jul 2025 According to an Alzamend Neuro media release, the company announced it will have a poster presentation at the Military Health System Research Symposium, being held from August 4-7, 2025, in Orlando, Florida.
  • 23 Jul 2025 According to an Alzamend Neuro media release, In May 2025, company dosed the first patient for the healthy human patients for the AL001 "Lithium in Brain" Studies at Massachusetts General Hospital.
  • 29 Jun 2025 Status changed from recruiting to active, no longer recruiting.

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top